# US 2023/0066217 A1 · Methods, systems and computer program products for tissue analysis using ultrasonic backscatter coherence

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0066217 A1
- Document ID: US20230066217A1
- Status: Published application
- Kind: A1
- Application number: 17/462,548
- Filed: 2021-08-31
- Published: 2023-03-02
- Earliest claimed: 2021-08-31
- Assignees: Duke University
- Applicants: Duke University
- Inventors: Katelyn Offerdahl; Gregg Trahey
- Web page: https://patentgrep.com/patent/US20230066217A1

## CPC

- A61B 8/485: {involving measuring strain or elastic properties}
- A61B 8/08: Clinical applications (A61B8/02, A61B8/04, A61B8/06 take precedence)
- A61B 8/5207: {involving processing of raw data to produce diagnostic data, e.g. for generating an image}
- A61B 8/5223: {for extracting a diagnostic or physiological parameter from medical diagnostic data (for algorithms to analyse biomedical images G06T7/0012)}
- G01N 29/0654: {Imaging}
- G01N 29/44: Processing the detected response signal {, e.g. electronic circuits specially adapted therefor (digital signal processing per se G06F17/00)}
- G01S 7/52036: {using analysis of echo signal for target characterisation}
- G01S 7/52042: {determining elastic properties of the propagation medium or of the reflective target (diagnostic techniques involving the measurement of strain A61B8/485)}
- G01S 15/8915: {using a transducer array}
- G16H 50/70: for mining of medical data, e.g. analysing previous cases of other patients
- A61B 8/12: in body cavities or body tracts, e.g. by using catheters
- A61B 8/4444: {related to the probe}
- G01N 2291/02475: Tissue characterisation
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G01S: RADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Methods, systems and computer program products for determining a property for a sample having a target region using ultrasound data from an ultrasound scanner include generating at least one spatial coherence curve based on ultrasound backscatter data in the target region, the spatial coherence curve comprising coherence values as a function of depth in the sample; and determining a property for a sample in response to the spatial coherence curve as a function of depth.

## Claims

### Claim 1

A method for determining a property for a sample having a target region using ultrasound data from an ultrasound scanner, the method comprising:
generating at least one spatial coherence curve based on ultrasound backscatter data in the target region, the spatial coherence curve comprising coherence values as a function of depth in the sample; and
determining a property for a sample in response to the spatial coherence curve as a function of depth.

### Claim 2 (depends on 1)

The method of claim 1, wherein the sample comprises in vivo liver tissue and the property comprises an estimation of fatty tissue or liver health.

### Claim 3 (depends on 2)

The method of claim 2, wherein the estimation of fatty tissue or liver health is based on an experimental model of actual clinical data comprising spatial coherence curves for clinical values of fatty tissue or liver health.

### Claim 4 (depends on 3)

The method of claim 3, wherein the estimation of fatty tissue or liver health indicates increased fatty tissue percentage or decreased liver health based on decreasing coherence values as a function of greater depth in the in vivo liver tissue.

### Claim 5 (depends on 4)

The method of claim 4, wherein determining a property for a sample in response to the spatial coherence curve as a function of depth further comprises fitting a curve to the spatial coherence curve for the liver tissue, and the property is determined based on a correlation between a curve fit value and known curve fit values for the experimental model of actual clinical data.

### Claim 6 (depends on 5)

The method of claim 5, wherein the estimation of fatty tissue or liver health comprises early stage steatosis.

### Claim 7 (depends on 5)

The method of claim 5, wherein the experimental model of actual clinical data comprises a first set of spatial coherence curves for clinical values of fatty tissue or liver health corresponding to late-stage steatosis above a threshold steatosis value, and a second set of spatial coherence curves for clinical values of fatty tissue or liver health corresponding to early-stage steatosis below the threshold steatosis value, the method further comprising determining whether the sample is above or below the threshold steatosis value based on ultrasound elastography.

### Claim 8 (depends on 7)

The method of claim 7, wherein the estimation of fatty tissue or liver health is determined based on the first set of spatial coherence curves if the ultrasound elastography indicates a steatosis value above the threshold steatosis value, and the estimation of fatty tissue or liver health is based on the second set of spatial coherence curves if the ultrasound elastography indicates a steatosis value below the threshold steatosis value.

### Claim 9

A computer program product for determining a property for a sample having a target region using ultrasound data from an ultrasound scanner, the computer program product comprising a non-transient computer readable medium having computer readable program code embodied therein, the computer readable program code comprising:
computer readable program code configured to generate at least one spatial coherence curve based on ultrasound backscatter data in the target region, the spatial coherence curve comprising coherence values as a function of depth in the sample; and
computer readable program code configured to determine a property for a sample in response to the spatial coherence curve as a function of depth.

### Claim 10 (depends on 9)

The computer program product of claim 9, wherein the sample comprises in vivo liver tissue and the property comprises an estimation of fatty tissue or liver health.

### Claim 11 (depends on 10)

The computer program product of claim 10, wherein the estimation of fatty tissue or liver health is based on an experimental model of actual clinical data comprising spatial coherence curves for clinical values of fatty tissue or liver health.

### Claim 12 (depends on 11)

The computer program product of claim 11, wherein the estimation of fatty tissue or liver health indicates increased fatty tissue percentage or decreased liver health based on decreasing coherence values as a function of greater depth in the in vivo liver tissue.

### Claim 13 (depends on 12)

The computer program product of claim 12, wherein the computer program readable program code for determining a property for a sample in response to the spatial coherence curve as a function of depth further comprises computer readable program code for fitting a curve to the spatial coherence curve for the liver tissue, and the property is determined based on a correlation between a curve fit value and known curve fit values for the experimental model of actual clinical data.

### Claim 14 (depends on 13)

The computer program product of claim 13, wherein the estimation of fatty tissue or liver health comprises early stage steatosis.

### Claim 15 (depends on 13)

The computer program product of claim 13, wherein the experimental model of actual clinical data comprises a first set of spatial coherence curves for clinical values of fatty tissue or liver health corresponding to late-stage steatosis above a threshold steatosis value, and a second set of spatial coherence curves for clinical values of fatty tissue or liver health corresponding to early-stage steatosis below the threshold steatosis value, the computer readable program code further comprising computer readable program code for determining whether the sample is above or below the threshold steatosis value based on ultrasound elastography.

### Claim 16 (depends on 15)

The computer program produce of claim 15, wherein the estimation of fatty tissue or liver health is determined based on the first set of spatial coherence curves if the ultrasound elastography indicates a steatosis value above the threshold steatosis value, and the estimation of fatty tissue or liver health is based on the second set of spatial coherence curves if the ultrasound elastography indicates a steatosis value below the threshold steatosis value.

### Claim 17

A system for determining a property for a sample having a target region using ultrasound data from an ultrasound scanner, the system comprising:
an ultrasound transducer array configured to generate at least one spatial coherence curve based on ultrasound backscatter data in the target region, the spatial coherence curve comprising coherence values as a function of depth in the sample; and
a signal analyzer configured to determine a property for a sample in response to the spatial coherence curve as a function of depth.

### Claim 18 (depends on 17)

The system of claim 17, wherein the sample comprises in vivo liver tissue and the property comprises an estimation of fatty tissue or liver health.

### Claim 19 (depends on 18)

The system of claim 18, wherein the estimation of fatty tissue or liver health is based on an experimental model of actual clinical data comprising spatial coherence curves for clinical values of fatty tissue or liver health.

### Claim 20 (depends on 19)

The system of claim 19, wherein the estimation of fatty tissue or liver health indicates increased fatty tissue percentage or decreased liver health based on decreasing coherence values as a function of greater depth in the in vivo liver tissue.
